In breast cancer cells, resveratrol was shown to inhibit estrogen receptor α (ERα) gene expression via phosphorylation of the NF-Y/p53/Sin3/HDAC1 complex, mediated by p38MAPK/CK2 signaling, including MCF-7 tamoxifen-resistant cells. Here, ESR1 is linked to breast cancer.